53
Participants
Start Date
January 27, 2016
Primary Completion Date
January 4, 2021
Study Completion Date
December 31, 2021
ONO-4538
Taichung Clinical Site 1, Taichung
Taichung Clinical Site 2, Taichung
Tainan Clinical Site 1, Tainan City
Tainan Clinical Site 2, Tainan City
Tainan Clinical Site 3, Tainan City
Taipei Clinical Site 1, Taipei
Taipei Clinical Site 2, Taipei
Taipei Clinical Site 3, Taipei
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY